Well, I found the panel members, if anyone cares. I think Feuerstein will have more specifics on the meeting. I heard that the person brought in from the EMEA was very critical. <a href="http://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM180629.pdf" rel="nofollow" target="_blank">http://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM180629.pdf</a> Bladerunner